244 related articles for article (PubMed ID: 26945875)
41. [Clinical analysis of 20 pregnant women with venous thromboembolic disease].
Sun P; Dong DN
Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):911-6. PubMed ID: 22333281
[TBL] [Abstract][Full Text] [Related]
42. Enoxaparin versus tinzaparin for venous thromboembolic prophylaxis during rehabilitation after acute spinal cord injury: a retrospective cohort study comparing safety and efficacy.
Marciniak CM; Kaplan J; Welty L; Chen D
PM R; 2012 Jan; 4(1):11-7. PubMed ID: 22269449
[TBL] [Abstract][Full Text] [Related]
43. Chemical venous thromboembolic prophylaxis is safe and effective for patients with traumatic brain injury when started 24 hours after the absence of hemorrhage progression on head CT.
Saadeh Y; Gohil K; Bill C; Smith C; Morrison C; Mosher B; Schneider P; Stevens P; Kepros JP
J Trauma Acute Care Surg; 2012 Aug; 73(2):426-30. PubMed ID: 22846950
[TBL] [Abstract][Full Text] [Related]
44. Caprini venous thromboembolism risk assessment permits selection for postdischarge prophylactic anticoagulation in patients with resectable lung cancer.
Hachey KJ; Hewes PD; Porter LP; Ridyard DG; Rosenkranz P; McAneny D; Fernando HC; Litle VR
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):37-44.e1. PubMed ID: 26386868
[TBL] [Abstract][Full Text] [Related]
45. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin.
Fuji T; Ochi T; Niwa S; Fujita S
J Orthop Sci; 2008 Sep; 13(5):442-51. PubMed ID: 18843459
[TBL] [Abstract][Full Text] [Related]
46. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
47. [Recurrent venous thromboembolic events--a prospective study].
Munteanu I; Munteanu I
Pneumologia; 2012; 61(4):214-20. PubMed ID: 23424945
[TBL] [Abstract][Full Text] [Related]
48. Timing and characteristics of venous thromboembolism after noncancer surgery.
Expósito-Ruiz M; Arcelus JI; Caprini JA; López-Espada C; Bura-Riviere A; Amado C; Loring M; Mastroiacovo D; Monreal M;
J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):859-867.e2. PubMed ID: 33248295
[TBL] [Abstract][Full Text] [Related]
49. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
Galambosi PJ; Ulander VM; Kaaja RJ
Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
[TBL] [Abstract][Full Text] [Related]
50. A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer.
Vedovati MC; Becattini C; Rondelli F; Boncompagni M; Camporese G; Balzarotti R; Mariani E; Flamini O; Pucciarelli S; Donini A; Agnelli G
Ann Surg; 2014 Apr; 259(4):665-9. PubMed ID: 24253138
[TBL] [Abstract][Full Text] [Related]
51. Incidence of venous thromboembolic events in enhanced recovery after surgery for colon cancer: a retrospective, population-based cohort study.
Vendler MMI; Haidari TA; Waage JE; Kleif J; Kristensen B; Gögenur I; Bertelsen CA;
Colorectal Dis; 2017 Nov; 19(11):O393-O401. PubMed ID: 28980383
[TBL] [Abstract][Full Text] [Related]
52. What is the effect of low-molecular weight heparin for venous thromboembolism prophylaxis compared with mechanical methods, on the occurrence of hemorrhagic and venous thromboembolic complications in patients with intracerebral hemorrhage? A critically appraised topic.
O'Carroll CB; Capampangan DJ; Aguilar MI; Bravo TP; Hoffman-Snyder CR; Wingerchuk DM; Wellik KE; Demaerschalk BM
Neurologist; 2011 Jul; 17(4):232-5. PubMed ID: 21712672
[TBL] [Abstract][Full Text] [Related]
53. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
54. A randomized study of the safety and efficacy of fondaparinux versus placebo in the prevention of venous thromboembolism after coronary artery bypass graft surgery.
Kolluri R; Plessa AL; Sanders MC; Singh NK; Lucore C
Am Heart J; 2016 Jan; 171(1):1-6. PubMed ID: 26699594
[TBL] [Abstract][Full Text] [Related]
55. [Venous thromboembolic disease in general surgery].
Arcelus Martínez JI
Med Clin (Barc); 2008 Nov; 131 Suppl 2():29-36. PubMed ID: 19087848
[TBL] [Abstract][Full Text] [Related]
56. Low-molecular-weight heparin for prevention of venous thromboembolism after varicose vein surgery in moderate-risk patients: a randomized, controlled trial.
San Norberto García EM; Merino B; Taylor JH; Vizcaíno I; Vaquero C
Ann Vasc Surg; 2013 Oct; 27(7):940-6. PubMed ID: 23993109
[TBL] [Abstract][Full Text] [Related]
57. Prevalence and countermeasures for venous thromboembolic diseases associated with spinal surgery: a follow-up study of an institutional protocol in 209 patients.
Akeda K; Matsunaga H; Imanishi T; Hasegawa M; Sakakibara T; Kasai Y; Sudo A
Spine (Phila Pa 1976); 2014 May; 39(10):791-7. PubMed ID: 24583727
[TBL] [Abstract][Full Text] [Related]
58. Comparative effectiveness of preventative therapy for venous thromboembolism after coronary artery bypass graft surgery.
Kulik A; Rassen JA; Myers J; Schneeweiss S; Gagne J; Polinski JM; Liu J; Fischer MA; Choudhry NK
Circ Cardiovasc Interv; 2012 Aug; 5(4):590-6. PubMed ID: 22739788
[TBL] [Abstract][Full Text] [Related]
59. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
60. Early venous thromboembolic event prophylaxis in traumatic brain injury with low-molecular-weight heparin: risks and benefits.
Dudley RR; Aziz I; Bonnici A; Saluja RS; Lamoureux J; Kalmovitch B; Gursahaney A; Razek T; Maleki M; Marcoux J
J Neurotrauma; 2010 Dec; 27(12):2165-72. PubMed ID: 20939698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
